Several clinical trials are investigating more sensitive techniques such as PSMA PET scans [55] that can be combined with radiation therapy to the whole pelvis [56] to better target the treatment to focal areas of metastatic disease. This evidence concerns the gene FOLH1 and metastatic neoplasm.